GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » E10

Nxera Pharma Co (Nxera Pharma Co) E10 : $-0.04 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Nxera Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.245. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.04 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Nxera Pharma Co's average E10 Growth Rate was -186.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Nxera Pharma Co was -43.60% per year. The lowest was -43.60% per year. And the median was -43.60% per year.

As of today (2024-05-22), Nxera Pharma Co's current stock price is $8.92. Nxera Pharma Co's E10 for the quarter that ended in Mar. 2024 was $-0.04. Nxera Pharma Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Nxera Pharma Co was 1167.62. The lowest was 32.58. And the median was 250.75.


Nxera Pharma Co E10 Historical Data

The historical data trend for Nxera Pharma Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co E10 Chart

Nxera Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 0.03 0.08 0.06 -0.01

Nxera Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 -0.01 -0.01 -0.04

Competitive Comparison of Nxera Pharma Co's E10

For the Biotechnology subindustry, Nxera Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Shiller PE Ratio falls into.



Nxera Pharma Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nxera Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.245/107.2000*107.2000
=-0.245

Current CPI (Mar. 2024) = 107.2000.

Nxera Pharma Co Quarterly Data

per share eps CPI Adj_EPS
201406 -0.019 98.000 -0.021
201409 0.022 98.500 0.024
201412 0.035 97.900 0.038
201503 0.038 97.900 0.042
201506 -0.140 98.400 -0.153
201509 -0.025 98.500 -0.027
201512 0.409 98.100 0.447
201603 -0.532 97.900 -0.583
201606 1.561 98.100 1.706
201609 -0.063 98.000 -0.069
201612 0.007 98.400 0.008
201703 -0.118 98.100 -0.129
201706 0.039 98.500 0.042
201709 -0.129 98.800 -0.140
201712 -0.151 99.400 -0.163
201803 -0.120 99.200 -0.130
201806 -0.187 99.200 -0.202
201809 -0.242 99.900 -0.260
201812 -0.310 99.700 -0.333
201903 0.120 99.700 0.129
201906 -0.075 99.800 -0.081
201909 0.127 100.100 0.136
201912 -0.004 100.500 -0.004
202003 -0.090 100.300 -0.096
202006 -0.165 99.900 -0.177
202009 0.056 99.900 0.060
202012 0.382 99.300 0.412
202103 -0.131 99.900 -0.141
202106 -0.128 99.500 -0.138
202109 0.052 100.100 0.056
202112 0.307 100.100 0.329
202203 -0.214 101.100 -0.227
202206 -0.134 101.800 -0.141
202209 0.026 103.100 0.027
202212 0.327 104.100 0.337
202303 -0.128 104.400 -0.131
202306 -0.057 105.200 -0.058
202309 -0.405 106.200 -0.409
202312 -0.015 106.800 -0.015
202403 -0.245 107.200 -0.245

Add all the adjusted EPS together and divide 10 will get our e10.


Nxera Pharma Co  (OTCPK:SOLTF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Nxera Pharma Co was 1167.62. The lowest was 32.58. And the median was 250.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Nxera Pharma Co E10 Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Nxera Pharma Co (Nxera Pharma Co) Business Description

Traded in Other Exchanges
Address
2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083
Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.

Nxera Pharma Co (Nxera Pharma Co) Headlines

From GuruFocus